ArticleESMO open2025

Trastuzumab deruxtecan adverse drug reactions reported to the UK's Medicines and Healthcare products Regulatory Agency via the Yellow Card Reporting System.

J Pearson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.